← Insider buys
AKBA

Akebia Therapeutics, Inc. · Healthcare

SVP, GC, Sec. Nicole R. Hadas sold $155K of Akebia Therapeutics, Inc.

Sold$155,188
$19.89Price
7,803Shares
−7%Stake

What AKBA did after the filing

Prices for AKBA after this filing aren't in yet.

Traded Mon, Oct 2. Filed Wed, Oct 4, 12:21 PM ET, during the session. Not investment advice.